Related Experiment Videos
Diuretics, potassium and arrhythmias in hypertensive coronary disease
Insights
Potassium-losing diuretics can increase cardiac electrical instability in patients with coronary artery disease, even with small drops in plasma potassium. Avoiding these changes is crucial for managing heart conditions.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Modest changes in plasma potassium levels may influence cardiac arrhythmia susceptibility.
- Patients with coronary artery disease (CAD) might be particularly vulnerable to these potassium-induced electrical changes.
Purpose of the Study:
- To investigate the impact of potassium-conserving versus potassium-losing diuretics on myocardial electrical excitability in patients with hypertension and CAD.
- To determine if minor decreases in plasma potassium concentrations affect cardiac electrical stability.
Main Methods:
- A randomized study comparing 8 weeks of amiloride (potassium-conserving) with 8 weeks of chlorthalidone (potassium-losing) in patients with mild essential hypertension and known CAD.
- Measurements included 24-hour Holter monitoring, monophasic action potential analysis, ventricular effective refractory period, and programmed ventricular stimulation.
- Plasma potassium, blood pressure, body weight, plasma renin, and noradrenaline were monitored.
Main Results:
- Plasma potassium levels were approximately 1 mmol/L lower during chlorthalidone treatment compared to amiloride.
- Chlorthalidone use was associated with increased ventricular ectopic beats, higher Lown grading, and enhanced myocardial electrical instability.
- Specific electrophysiological findings included increased action potential upslope and duration, and a prolonged ventricular effective refractory period.
Conclusions:
- Potassium-losing diuretic therapy can increase myocardial electrical excitability in patients with ischemic heart disease.
- Even minor reductions in plasma potassium should likely be avoided in this patient population.
- This highlights the importance of careful electrolyte management in cardiovascular patients receiving diuretics.
Abstract:
It has been proposed that modest changes in plasma potassium can alter the tendency towards cardiac arrhythmias. If this were so, patients with coronary artery disease might be especially susceptible. Thus, myocardial electrical excitability was measured in patients with mild essential hypertension and known coronary artery disease after 8 weeks of treatment with a potassium-conserving diuretic (amiloride) and a similar period on a potassium-losing diuretic (chlorthalidone) in a randomised study. Plasma potassium concentrations were on average 1 mmol/L lower during the chlorthalidone phase compared to amiloride therapy. Blood pressure and volume states as assessed by bodyweight, plasma renin and noradrenaline (norepinephrine) concentrations were similar on the 2 regimens. Compared to amiloride treatment, the chlorthalidone phase was associated with an increased frequency of ventricular ectopic beats (24-hour Holter monitoring) and a higher Lown grading, increased upslope and duration of the monophasic action potential, prolonged ventricular effective refractory period, and increased electrical instability during programmed ventricular stimulation. The above results indicate that because potassium-losing diuretic therapy can increase myocardial electrical excitability in patients with ischaemic heart disease, even minor falls in plasma potassium concentrations are probably best avoided in such patients.